| Name | flucloxacillin |
|---|---|
| Synonyms |
(2S,5R,6R)-6-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid
(2S,5R,6R)-6-[[3-(2-chloro-6-fluoro-phenyl)-5-methyl-isoxazole-4-carbonyl]amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid Floxapen Phenylbutazone Impurity 34 Culpen (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Fluoxacillin EINECS 226-051-0 Flucil Flucloxacillin //BP 6-[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolecboxamido]penicillanic acid 6-[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolecboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid Ladropen MFCD00864886 Fluchlxacillin Floxacillin 4-Thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid, 6-[3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolecboxamido]-3,3-dimethyl-7-oxo- (8CI) Penplus Stafoxil [3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]penicillin BRL 2039 Flucloxcillin 4-Thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid, 6-[[[3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R) Flopen (2S,5R,6R)-6-({[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Abboflox FLUCLOXACILLIN 4-Thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid, 6-[[[3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, [2S-(2α,5α,6β)] (2S,5R,6R)-6-(3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-cboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid (Cloxacillin Impurity) FLOXACILLIN (2S,5R,6R)-6-[[3-(2-chloro-6-fluoro-phenyl)-5-methyl-1,2-oxazol-4-yl]cbonylamino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]htane-2-cboxylic acid Flupen Staphcil Staphylex Staphlipen FK 900 |
| Description | Flucloxacillin is an active antibiotic against gram-positive and gram-negative bacteria[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Flucloxacillin (200 mg/kg; i.p.; three times/day, for 21 days; male Wistar rats) has effective against the most common bacterial strains in periprosthetic infection[1]. Animal Model: Male Wistar rats[1] Dosage: 200 mg/kg Administration: Intraperitoneal injection; three times/day, for 21 days Result: Reducted germs in the biofilm and in the bone tissue. |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 677.3±55.0 °C at 760 mmHg |
| Molecular Formula | C19H17ClFN3O5S |
| Molecular Weight | 453.872 |
| Flash Point | 363.4±31.5 °C |
| Exact Mass | 453.056152 |
| PSA | 138.04000 |
| LogP | 2.60 |
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
| Index of Refraction | 1.672 |